|
CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial |
|
|
|
Titel: |
CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial |
Auteur: |
Laterre, Pierre-François Colin, Gwenhael Dequin, Pierre-François Dugernier, Thierry Boulain, Thierry Azeredo da Silveira, Samareh Lajaunias, Frédéric Perez, Antonio François, Bruno |
Verschenen in: |
The lancet infectious diseases |
Paginering: |
Jaargang 19 () nr. 6 pagina's 620-630 |
Jaar: |
2019 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|